Member Info for Bluelight

Additionally.. Its taken 1 day to find out that you can't take the Pfizer one if you are allergic to anything. You can't tell me Pfizer didn't know that in their sample testing. What else can cause complications? No one knows because there's no bloody data on it! What happens if if wipes out anyone with red hair, or all Sagitarians. The lack of study data is astonishing, and yet its hailed for political reasons as a magical cure.

My issue with the vaccines is the speed theyve rushed them out. They have what 3m worth of data on limited test subjects. In no way is that enough data to be confident of side effects. We all want an end to the virus, but why on gods earth would you inject yourself with something that you have no idea what it will do to you by this time next year. Its been rushed through as a political and economic tool, not a health tool. Good luck to any that wish to take it early, but for me I'll wait until at least next summer to see what effects it has on the first recipients.

11-12% rise tomorrow, nice round £10 close

Nothing news or RNS related. it's simply the return of sentiment. may people will have sold or held off due to vaccine headlines. Now that's out of the way and prices are climbing again, those people will be buying in to participate in the climb back to a true valuation. Its 100% sentiment driven.

I think you've hit the nailed on the head their HarChris. the negative sentiment on vaccine is out of the way, and the reality is now showing itself. As many of us have suggested, vaccines wont reduce testing, particularly not in this case as its so globally widespread, and such a high degree of wariness on the vaccines speed of being released. Read yesterday that at least 30% of UK population wont take the vaccine as its been rushed. As soon as we get the headlines, I got the vaccine but still got covid that number will go up substantially.

It will simply be that it held a support of 77p, which is very bullish now as it will rise back to the prior levels it was before it got such a kicking. Its a technical move, which is very positive.

Thats assuming they havent hedged FX. If they have large us sales orders, I suspect they will have an FX hedge in place to lock in set margin.

Indeed, I also dont expect sales until Jan. I hold as I expect new contracts to be RNS'd. I've been dissapointed on that so far mind you. I'd argue they need to start worrying about price action more now they're in bed with the likes of BlackRock. They wont be quiet or sit on the sidelines if they arent putting shareholder returns high on their priority list.

That's the problem, none of us know jack all for definite as the company wont release any info. Excellent posters can do as much research as they like but at the end of the day the price wont react until the company release some info on sales and/or contracts. It's a rollercoaster, and it need not be. Simply providing more confirmed info to the market would allow for steady growth in company value, as people wont need to guess. Im not being negative, after all BlackRock dont invest all that cash without expecting a significant return. Just feel at the moment NCYT are dropping the ball on shareholder interaction

I will repeat my view I've long held, for an AIM share you can't only do 6m sales updates as the market is too volatile on no news. Yes we all know sales will be superb, but whilst there is no news prices will fail to be stimulated. Why not give the price momentum be releasing regular quarterly updates. Its a rapidly evolving covid driven market, and as such its not prudent to bury their head in the sand for 6m.

All good and well, but its about time we starting hearing about some information. This silence is starting to wear on investors patience.

Its also a big chunk of shares in sticky hands. Blackrock aren't day traders, they'll be sat on the position, maybe fine tuning occasionally, but basically those shares will be out of circulation. Might actually make price action more volatile, but when it breaks upwards it will shoot up much quicker than the last rally.

Given Blackrocks size and capital at stake I doubt they do more than take Numis broker info as a useful guide. Putting such huge sums at stake, they will have dedicated analyst teams who dig into every fine detail before engaging in such a big position build. It's extremely positive for NCYT, can't stress that enough. Their positioning shows where the price is going. Surprised the price didn't react more today, but I have no doubt 'le surge' is coming very soon indeed.

We don't RNS anything less than a billion nowadays it seems, what's a few hundred million contracts amongst friends.

For what's basically been a flat week, can't help but feel like it's been a good one given today's nice climb. Personally bought two more clips this week, one at 750, and one at 680, so all in all a good weeks work.

If it's the RNS we are expecting it wont be £10 it'll be £15+

A vaccine isn't a threat at all, it's an opportunity. the uninformed assume a vaccine and testing are mutually exclusive, even when its been made abundantly clear by the powers that be, that isn't the case. To have an effective vaccine, you need a massive testing infrastructure, for years. The virus isn't a switch you turn off and on.

Cyclicals (airlines banks etc) all started to drop like a stone this morning. Watch sentiment change 180 degrees on this

I don't think long time investors have any doubts HarChris. You wont hear much complaining from the usual faces who've been around and seen it before. Fundamentals are sound, and for me I just buy on dips at set amounts as I'm more than comfortable with the companies position, particularly so at this low valuation. The toing and froing with be from short term traders, and punters, oh this news is super bullish, oh no this is awful, blah blah. In the meantime NCYT goes about earning more each day and filling the bank account. if you cant afford to be down 20% on here, or get uber excited when its up 20% then shouldnt really be involved in it in my view.

The stage 1 nhs contract alone was 406m. I wouldn't be surprised if earnings are over 1bn for the year end. That said, we are all just using best estimates based on available info, it would be nice to get some decent guidance from NCYT, rather than the 'significantly above prior numbers'. Either way, one of the cheapest stocks out there, and alot of value to be unlocked.